About Dr. Gibofsky
Dr. Allan Gibofsky has conducted extensive research on rheumatic fever and rheumatoid arthritis. He is a Professor of Medicine at Weill Cornell Medical College and an Attending Rheumatologist at Hospital for Special Surgery, where he is co-Director of the Clinic for Inflammatory Arthritis and Biologic Therapy.
Profile Video
Departments
Patient Stories
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Physician, Hospital for Special Surgery
Professor of Medicine, Weill Cornell Medical College
Certification
Rheumatology
Internal Medicine
Awards
Master, The American College of Rheumatology, 2014
Castle Connolly Top Doctors in New York Metro Area, 2005-2022
New York Magazine Top Doctors, 2021, 2022
Education
MD, Weill Cornell Medical School, New York
JD, Fordham University School of Law
Residency
The New York Hospital, New York
Fellowship
Hospital for Special Surgery - Rockefeller University
State Licensure
Languages
English
Publications by Dr. Gibofsky
Patient Education
Blog Posts
Research
Clinical Trials
Industry Relationships
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Gibofsky as of February 27, 2023.
- AbbVie Inc. - Advisory Board; Consultant; Ownership Interest; Speakers' Bureau
- Acquist (formerly Relburn Pharmaceuticals) - Advisory Board
- American College of Rheumatology - Committee Member
- Amgen - Consultant; Speakers’ Bureau
- Boehringer Ingelheim - Author
- Johnson & Johnson - Ownership Interest
- Pfizer, Inc. - Advisory Board; Author; Consultant; Ownership Interest; Speakers' Bureau
- Sahumed, LLC - Consultant
- The Rheumatology Education Group - Speakers' Bureau
- UptoDate - Author
- US Food and Drug Administration - Consultant
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.